Vaccines for Prevention of Hantaviral Fevers

Abstract

Hantaviruses are highly pathogenic causative agents of hantaviral fevers, including hemorrhagic fever with renal syndrome, registered among people in countries of the Eurasian continent and a disease called «hantavirus pulmonary syndrome» – in the countries of North and South America. More recently, the spread of hantaviral diseases has been detected in Africa. There are still no drugs for specific antiviral therapy. The most promising method of dealing with hantaviral fevers is specific prophylaxis, that is, vaccination of the population against hantaviruses, which determine the endemicity of different territories. This review summarizes current data on existing and developed vaccines against hantaviral fevers.

Keywords

• hemorhagic fever with renal syndrome
• hantavirus pulmonary syndrome
• virus puumala
• virus dobrava-belgrade
• virus hantaan
• virus seoul
• virus amur
• virus sin nombre
• virus andes